LAM
ANIX icon

LifePro Asset Management’s Anixa Biosciences ANIX Stock Holding History

LifePro Asset Management’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$32.8K Sell
10,410
-350
-3% -$1.08K 0.02% 146
2024
Q2 		$23.8K Buy
+10,760
New +$30.5K 0.02% 127

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $4.86B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LifePro Asset Management's ANIX Position: Q3 2024 in Review

LifePro Asset Management reduced its Anixa Biosciences (ANIX) stake by 3.3% in Q3 2024, selling an estimated $1.08K and leaving 10,410 shares worth $32.8K. The position accounts for 0.02% of the portfolio, ranked #146.

LifePro Asset Management first reported a position in ANIX in Q2 2024 and has held it in 2 quarters since. 58 funds tracked by Wall St. Rank hold ANIX as of Q3 2024.

  • LifePro Asset Management held 10,410 shares of Anixa Biosciences worth $32.8K as of Q3 2024.
  • LifePro Asset Management sold 350 Anixa Biosciences shares in Q3 2024, an estimated $1.08K.
  • Anixa Biosciences made up 0.02% of LifePro Asset Management's portfolio in Q3 2024, its #146 holding.
  • LifePro Asset Management first reported a position in Anixa Biosciences in Q2 2024 and has held it in 2 quarters since.
  • 58 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2024.

Based on LifePro Asset Management's 13F filing for Q3 2024, filed 9 Oct 2024.